References
- Barrett, J.C., Fry, B., Maller, J., Daly, M.J. (2005). Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-265.
- Chang, L.C., Huang, K.C., Wu, Y.W., Kao, H.L., Chen, C.L., Lai, L.P., Hwang, J.J., Yang, W.S. (2009). The clinical implications of blood adiponectin in cardiometabolic disorders. J. Formos. Med. Assoc., 108, 353-366.
- Chen, M.P., Tsai, J.C., Chung, F.M., Yang, S.S., Hsing, L.L., Shin, S.J., Lee, Y.J. (2005). Hypoadiponectinemia is associated with ischemic cerebrovascular disease. Arterioscler. Thromb. Vasc. Biol., 25, 821-826.
- Hegener, H.H., Lee, I.M., Cook, N.R., Ridker, P.M., Zee, R.Y. (2006). Association of adiponectin gene variations with risk of incident myocardial infarction and ischemic stroke: A nested case-control study. Clin. Chem., 52, 2021-2027.
- Heid, I.M., Wagner, S.A., Gohlke, H., Iglseder, B., Mueller, J.C., Cip, P., Ladurner, G., Reiter, R., Stadlmayr, A., Mackevics, V., Illig, T., Kronenberg, F., Paulweber, B. (2006). Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes, 55, 375-384.
- Hu, E., Liang, P., Spiegelman, B.M. (1996). AdipoQ is a novel adipose- specific gene dysregulated in obesity. J. Biol. Chem., 271, 10697-10703.
- Iwashima, Y., Katsuya, T., Ishikawa, K., Ouchi, N., Ohishi, M., Sugimoto, K., Fu, Y., Motone, M., Yamamoto, K., Matsuo, A., Ohashi, K., Kihara, S., Funahashi, T., Rakugi, H., Matsuzawa, Y., Ogihara, T. (2004). Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension, 43, 1318-1323.
- Kumada, M., Kihara, S., Sumitsuji, S., Kawamoto, T., Matsumoto, S., Ouchi, N., Arita, Y., Okamoto, Y., Shimomura, I., Hiraoka, H., Nakamura, T., Funahashi, T., Matsuzawa, Y. (2003). Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler. Thromb. Vasc. Biol., 23, 85-89.
- Kyriakou, T., Collins, L.J., Spencer-Jones, N.J., Malcolm, C., Wang, X., Snieder, H., Swaminathan, R., Burling, K.A., Hart, D.J., Spector, T.D., O'Dell, S.D. (2008). Adiponectin gene ADIPOQ SNP associations with serum adiponectin in two female populations and effects of SNPs on promoter activity. J. Hum. Genet., 53, 718-727.
- Li, L.L., Kang, X.L., Ran, X.J., Wang, Y., Wang, C.H., Huang, L., Ren, J., Luo, X., Mao, X.M. (2007). Associations between 45T/G polymorphism of the adiponectin gene and plasma adiponectin levels with type 2 diabetes. Clin. Exp. Pharmacol. Physiol., 34, 1287-1290.
- Mackevics, V., Heid, I.M., Wagner, S.A., Cip, P., Doppelmayr, H., Lejnieks, A., Gohlke, H., Ladurner, G., Illig, T., Iglseder, B., Kronenberg, F., Paulweber, B. (2006). The adiponectin gene is associated with adiponectin levels but not with characteristics of the insulin resistance syndrome in healthy Caucasians. Eur. J. Hum. Genet., 14, 349-356.
- Matsuda, M., Shimomura, I., Sata, M., Arita, Y., Nishida, M., Maeda, N., Kumada, M., Okamoto, Y., Nagaretani, H., Nishizawa, H., Kishida, K., Komuro, R., Ouchi, N., Kihara, S., Nagai, R., Funahashi, T., Matsuzawa, Y. (2002). Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J. Biol. Chem., 277, 37487-37491.
- Matsuzawa, Y., Shimomura, I., Kihara, S., Funahashi, T. (2003). Importance of adipocytokines in obesity-related diseases. Horm. Res., 60 (Suppl 3), 56-59.
- Menzaghi, C., Trischitta, V., Doria, A. (2007). Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes, 56, 1198-1209.
- Ouchi, N., Kihara, S., Funahashi, T., Matsuzawa, Y., Walsh, K. (2003). Obesity, adiponectin and vascular inflammatory disease. Curr. Opin. Lipidol., 14, 561-566.
- Pischon, T., Girman, C.J., Hotamisligil, G.S., Rifai, N., Hu, F.B., Rimm, E.B. (2004). Plasma adiponectin levels and risk of myocardial infarction in men. JAMA, 291, 1730-1737.
- Potapov, V.A., Chistiakov, D.A., Dubinina, A., Shamkhalova, M.S., Shestakova, M.V., Nosikov, V.V. (2008). Adiponectin and adiponectin receptor gene variants in relation to type 2 diabetes and insulin resistance-related phenotypes. Rev. Diabet. Stud., 5, 28-37.
- Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., Maller, J., Sklar, P., de Bakker, P.I., Daly, M.J., Sham, P.C. (2007). PLINK: A tool set for whole-genome association and population-based linkage analyses. Amer. J. Hum. Genet., 81, 559-575.
- Shimano, M., Shibata, R., Tsuji, Y., Kamiya, H., Uchikawa, T., Harata, S., Muto, M., Ouchi, N., Inden, Y., Murohara, T. (200). Circulating adiponectin levels in patients with atrial fibrillation. Circ. J., 72, 1120-1124.
- Spranger, J., Kroke, A., Mohlig, M., Bergmann, M.M., Ristow, M., Boeing, H., Pfeiffer, A.F. (2003). Adiponectin and protection against type 2 diabetes mellitus. Lancet, 361, 226-228.
- Szopa, M., Malczewska-Malec, M., Wilk, B., Skupien, J., Wolkow, P., Malecki, M.T., Sieradzki, J. (2009). Variants of the adiponectin gene and type 2 diabetes in a Polish population. Acta Diabetol., January.
- Vasseur, F., Meyre, D., Froguel, P. (2006). Adiponectin, type 2 diabetes and the metabolic syndrome: Lessons from human genetic studies. Expert Rev. Mol. Med., 8, 1-12.
- Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R.E., Tataranni, P.A. (2001). Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab., 86, 1930-1935.
- Xita, N., Georgiou, I., Chatzikyriakidou, A., Vounatsou, M., Papassotiriou, G.P., Papassotiriou, I., Tsatsoulis, A. (2005). Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome. Clin. Chem., 51, 416-423.
- Yang, W.S., Lee, W.J., Funahashi, T., Tanaka, S., Matsuzawa, Y., Chao, C.L., Chen, C.L., Tai, T.Y., Chuang, L.M. (2001). Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J. Clin. Endocrinol. Metab., 86, 3815-3819.